HD

Wave Life Sciences Highlights Recent Achievements and Upcoming 2024 Milestones

Retrieved on: 
Monday, January 8, 2024
Well, RNA, Conference, Science, Wave, Messenger, Research, AAT, Chemistry, Pizzicato, Small RNA, Lung, Weight, Health, Disease, MBA, MD, Mouse, HD, Human, Serum, GSK, Mutation, Genetics, Coronary artery disease, Obesity, Genomics, Concentration ratio, Central nervous system, Patient, Liver disease, Lof, HTT, Medicine, Therapy, Oligonucleotide, NHP, CTA, Vaccine

We expect 2024 will be an inflection year that will drive significant value for Wave, our shareholders, and most importantly, for the patients who will benefit from our research,” said Paul Bolno, MD, MBA, President and Chief Executive Officer of Wave Life Sciences.

Key Points: 
  • We expect 2024 will be an inflection year that will drive significant value for Wave, our shareholders, and most importantly, for the patients who will benefit from our research,” said Paul Bolno, MD, MBA, President and Chief Executive Officer of Wave Life Sciences.
  • Expected milestones: Wave plans to deliver proof-of-mechanism data in individuals with AATD in 2024.
  • Expected milestones: Wave expects to deliver data, including dystrophin protein expression from muscle biopsies at 24 weeks, in the third quarter of 2024.
  • A live webcast of this presentation will be available on the Investor Relations page of the Wave Life Sciences website at http://ir.wavelifesciences.com .

Sage Therapeutics to Provide Business Updates at 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Monday, January 8, 2024
Research, Pharmaceutical, Consumer, Mental Health, Parenting, Clinical Trials, Science, Baby, Maternity, Neurology, Biotechnology, Women, FDA, Health, Conference, Essential tremor, PPD, PAM, Woman, Physician, DSM-IV codes, USAN, Therapy, HD, Postpartum depression, Standard of care, PD, GABAA, Webcast, Patient, NMDA, Pharmaceutical industry

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced that Chief Executive Officer Barry Greene will discuss the Company’s key business drivers for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California.

Key Points: 
  • Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced that Chief Executive Officer Barry Greene will discuss the Company’s key business drivers for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, California.
  • Sage and Biogen field sales teams are engaging in promotional dialogues with health care professionals (HCPs) who actively identify and treat women with PPD.
  • Sage is advancing a portfolio of early-stage and clinical programs featuring internally discovered novel chemical entities targeting the GABAA and NMDA receptor systems.
  • A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

TomTom and Mitsubishi Electric collaborate to advance Automated Driving

Retrieved on: 
Monday, January 8, 2024
Travel, TomTom, GPS, Level 5, HD, ADAS, Element, LAS, Mitsubishi Electric, Mapping, Safety, CES, QZSS, Mitsubishi Group, Satellite navigation device

With this collaboration, the companies are developing hardware solutions that provide the highly accurate navigation data required for automated driving.

Key Points: 
  • With this collaboration, the companies are developing hardware solutions that provide the highly accurate navigation data required for automated driving.
  • LAS VEGAS, Jan. 08, 2024 (GLOBE NEWSWIRE) -- TomTom ( TOM2 ), the location technology specialist, and Mitsubishi Electric (TOKYO: 6503) today announced they are integrating technologies to develop new solutions and drive innovation in automated driving.
  • Through this collaboration, TomTom’s High Definition (HD) Map will power Mitsubishi Electric’s High-Definition Locator hardware, providing the highly accurate data required for automated driving.
  • Ask for a demonstration of TomTom HD Map running on Mitsubishi Electric’s High-Definition Locator hardware and find out about the other projects TomTom is currently working on in collaboration with our partners.

Advantech Brings Retail to NRF 2024: Retail's Big Show

Retrieved on: 
Friday, January 5, 2024
Software, Other Retail, Payments, Hardware, Data Management, Technology, IOT (Internet of Things), Retail, POS, COM, Multimedia, Sale, System, LED, NRF, USB, HD, Series, Longevity, Connection, Corrosion, Video game

View the full release here: https://www.businesswire.com/news/home/20240105608038/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240105608038/en/
    The USC-300 Series, an All-in-One POS system, has been awarded the prestigious 2024 Taiwan Excellence Award.
  • This award honors the most innovative Taiwanese products that deliver substantial value to users worldwide and symbolizes Advantech commitment to excellence.
  • Tailored for retail and hospitality environments, the USC-300 Series seamlessly blends into any store decoration with sophisticated aesthetics and versatile design.
  • For more information or to set up an appointment to meet with Advantech at NRF 2024, contact [email protected] .

Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline

Retrieved on: 
Friday, January 5, 2024
DSM-IV codes, Spinocerebellar ataxia, Biotechnology, Research, SCA1, HD, Therapy, BNP Paribas Fortis, Investment, SCA3, Patient, Safety, Ackermans & van Haaren, Huntington's disease, Pharmaceutical industry

"This financing positions us to accelerate our efforts to advance our lead program VO659, currently in a Phase 1/2a clinical study of patients with spinocerebellar ataxia types 3 and 1 and Huntington's disease," said Micah Mackison, chief executive officer at Vico.

Key Points: 
  • "This financing positions us to accelerate our efforts to advance our lead program VO659, currently in a Phase 1/2a clinical study of patients with spinocerebellar ataxia types 3 and 1 and Huntington's disease," said Micah Mackison, chief executive officer at Vico.
  • The financing will also help support discovery and research efforts to further expand the company's pipeline in other genetic neurological diseases.
  • The company also announced that Jeroen Vangindertael, Ph.D., investment manager at AvH, will join Vico's board of directors.
  • "We are proud to support Vico in this financing round as they continue to advance their lead clinical program and further develop a portfolio of novel antisense oligonucleotides," said Dr. Vangindertael.

China Passenger Car Driving-parking Integrated Solution Industry Report 2023: With the Declining Share of the Self-development Model, Suppliers' Solutions Blossom - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 3, 2024
Automotive, General Automotive, VPA, Lidar, Partnership, Baidu, Sale, OEM, ODIN, BEV, PDC, City, HWA, NOA, Aptiv, Great Wall Motor, HD, Research, Original equipment manufacturer, SUV, DJI, TI, Perception, NIO, BYD, Radar, Mount Hua, AVM, OTA, J3, Hongqi (marque), Tegra, Satellite navigation device

The "China Passenger Car Driving-parking Integrated Solution Industry Report, 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "China Passenger Car Driving-parking Integrated Solution Industry Report, 2023" report has been added to ResearchAndMarkets.com's offering.
  • Research on driving-parking integration: with the declining share of the self-development model, suppliers' solutions blossom.
  • For example, Aptiv's driving-parking integrated solution launched in April 2023 can be divided into Core and Pro versions by configuration.
  • Hong Jing Drive's driving-parking integrated solution introduced in December 2022 is based on one J3 chip and supports 5R5V12U.

US Neurologists Optimistic Regarding the Huntington’s Disease Treatment Pipeline, Emphasizing Halting Neurodegeneration as Leading Treatment Priority

Retrieved on: 
Wednesday, January 3, 2024
Movement, Family, Caudate nucleus, PTC, SOM, Disease, Chorea, Frustration, Brain, Research, HD, Therapy, Tardive dyskinesia, Neurology, Dementia, Huntingtin, Atrophy, Pathology, PTC Therapeutics, Optimism, Patient, Movement disorder, Neuron, Pharmaceutical industry

Thus, often without full awareness, patients lose motor control, experience psychiatric symptoms, and cognitive decline.

Key Points: 
  • Thus, often without full awareness, patients lose motor control, experience psychiatric symptoms, and cognitive decline.
  • A neurologist’s perspective from a recent research study suggests:
    “A Huntington’s patient is almost a combination of Alzheimer’s, tardive dyskinesia, Parkinson’s - all in one.
  • Recognizing the significant treatment unmet needs, Spherix Global Insights conducted a market landscape study, seeking insights from neurologists managing HD.
  • Additionally and unaided, neurologists also mentioned Annexon Biosciences’ ANX005, Azevan Pharmaceuticals’ SRX246, SOM Biotech’s SOM3355, and Vaccinex, Inc.’s pepinemab.

Global and China Automotive Cockpit Domain Controller Research Report 2023 Featuring 10 International Cockpit Domain Controller Vendors and 16 Chinese Cockpit Domain Controller Vendors - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 3, 2024
Vehicle Technology, Automotive Manufacturing, Manufacturing, Automotive, BSD, GPT, Neusoft, HUD, OMS, AMD, SAIC, AEB, ACC, Great Wall Motor, Chang'an, Research, HD, Visteon, Original equipment manufacturer, ADAS, Intelligence, 3D, GPU, Human, Socs, CPU, BOM, Lotus, SOC, Tier 1, Safety, AVP, AVM, OTA, Li Auto L9, LCC, Great Wall of China, DMS, Video game

The "Global and China Automotive Cockpit Domain Controller Research Report, 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global and China Automotive Cockpit Domain Controller Research Report, 2023" report has been added to ResearchAndMarkets.com's offering.
  • In 2022, the installations of Qualcomm 8155-based cockpit domain controller products in China totaled about 850,000 sets, a figure to be higher in 2023.
  • At the time of mass production of Qualcomm 8155-based cockpit domain controller products, high-performance cockpit domain controller products based on Qualcomm 8295 and other chips are also production-ready.
  • According to the functions integrated, the cockpit domain controller product solutions evolve in the following forms:
    The first form is cockpit domain controller products mainly integrating cockpit functions.

Tencent Music Entertainment Group and Universal Music Group Extend Multi-year Strategic Licensing Agreement

Retrieved on: 
Wednesday, January 3, 2024
Atmos, Music, Ecosystem, Family, Partnership, TME, Tencent Music, HKEX, QQ Music, HD, UMG, Growth, Creativity, EVP, Universal Music Group

SHENZHEN, China, Jan. 3, 2024 /PRNewswire/ -- Tencent Music Entertainment Group ("TME," or the "Company") (NYSE: TME and HKEX: 1698), the leading online music and audio entertainment platform in China, and Universal Music Group ("UMG"), the world's leading music-based entertainment company, today announced the renewal of a multi-year strategic licensing agreement, fortifying their shared commitment to creating value for artists and exceptional experiences for music lovers.

Key Points: 
  • SHENZHEN, China, Jan. 3, 2024 /PRNewswire/ -- Tencent Music Entertainment Group ("TME," or the "Company") (NYSE: TME and HKEX: 1698), the leading online music and audio entertainment platform in China, and Universal Music Group ("UMG"), the world's leading music-based entertainment company, today announced the renewal of a multi-year strategic licensing agreement, fortifying their shared commitment to creating value for artists and exceptional experiences for music lovers.
  • Under the agreement, TME continues to have access to UMG's music catalogue for QQ Music, Kugou Music, Kuwo Music, and WeSing.
  • Adam Granite, UMG's EVP of Market Development, said, "We are pleased to extend our licensing agreement with TME for the Chinese market.
  • UMG will continue to work with TME to bring the very best in music to these passionate music consumers, and to explore new ways to enhance their listening experiences."

Perfect Corp. Set to Reveal Top AI Tech Trends of 2024 at CES with Game-Changing ‘Beautiful AI’ Innovations Across Beauty, Skincare, Fashion, and Generative AI

Retrieved on: 
Tuesday, January 2, 2024
Fashion, Cosmetics, Retail, Audio, Video, Artificial Intelligence, Software, Finance, Internet, Online Retail, Professional Services, Technology, Mobile, Wireless, Fintech, Digital Marketing, Public Relations, Investor Relations, Marketing, Advertising, Communications, Apps, Applications, VR, Multimedia, Synthetic media, Consumer Electronics Show, Gen, HD, Beauty, AI, 3D, Speech, Business development, Generative, Machine learning, Growth, Perfect, Carbon, CES, Corp, 2D, Jewellery, Algorithm, Life, Online shopping

View the full release here: https://www.businesswire.com/news/home/20240102596355/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240102596355/en/
    Perfect Corp. to demonstrate game-changing ‘Beautiful AI’ innovations across beauty, skincare, fashion, and generative AI at CES 2024.
  • Find out more about the session here https://www.ces.tech/sessions-events/retail.aspx
    In the ever-evolving landscape of technology, 2024 promises to be a groundbreaking year for Generative AI.
  • The advantages of customized virtual fittings with Generative AI will equip customers to make more confident purchasing decisions.
  • With the rapid adoption of Generative AI for beauty and fashion inspiration, consumer interest in Generative AI is also increasing.